Fortis Hospital

Noida 201301

1 studies enrolling now · 7 studies all time

What they study most

Arthritis, Psoriatic, Breast Cancer, Carcinoma, Ovarian Epithelial, Colitis, Ulcerative, Crohn's Disease, Fallopian Tube Adenocarcinoma, Fallopian Tube Neoplasms, Fallopian Tube Serous Adenocarcinoma, Inflammatory Bowel Diseases, Ovarian Cancer, Ovarian Neoplasms, Ovarian Serous Adenocarcinoma

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis — Recruiting now
• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis — Running, not enrolling
• A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) — Running, not enrolling
• Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery — Running, not enrolling
• A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC — Running, not enrolling
• Trial of Myocet in Metastatic Breast Cancer — Status unconfirmed